Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures
- PMID: 27536596
- PMCID: PMC4972623
- DOI: 10.5371/hp.2015.27.1.9
Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures
Abstract
Osteoporosis is a metabolic disease that is increasing in prevalence as people live longer. Because the orthopedic surgeon is frequently the first and often the only physician to manage patients with osteoporotic hip fractures, every effort should be made to prevent future fractures. A multidisciplinary approach is essential in treatment of osteoporotic fractures. Basic treatment includes calcium and vitamin D supplementation, fall prevention, hip protection, and balance and exercise programs. Currently available pharmacologic agents are divided into antiresorptive and anabolic groups. Antiresorptive agents such as bisphosphonates limit bone resorption through inhibition of osteoclastic activity. Anabolic agents such as parathyroid hormone promote bone formation.
Keywords: Hip fractures; Medication; Osteoporosis.
Figures
References
-
- Shea B, Wells G, Cranney A, et al. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis VII Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23:552–559. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
